ask="1.30"
ask_size="200"
average_daily_volume="758264"
bid="1.10"
bid_size="3800"
book_value="1.37"
change="+0.05"
change_from_200_day_moving_average="-1.67"
change_from_50_day_moving_average="-1.03"
change_from_52_week_high="-7.65"
change_From_52_week_low="0.20"
change_in_percent="+4.17%"
close="1.25"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.31"
ebitda="-61.52M"
eps_estimate_current_year="-1.55"
eps_estimate_next_quarter="-0.37"
eps_estimate_next_year="-1.35"
ex_dividend_date="N/A"
float_shares="36032000"
high="1.25"
high_52_weeks="8.90"
last_trade_date="2/1/2017"
last_trade_price="1.25"
last_trade_size="7653"
last_trade_time="4:00pm"
low="1.20"
low_52_weeks="1.05"
market_capitalization="66.15M"
moving_average_200_day="2.92"
moving_average_50_day="2.28"
name="Regulus Therapeutics Inc."
notes="N/A"
one_year_target_price="8.00"
open="1.20"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="-57.16%"
percent_change_from_50_day_moving_average="-45.23%"
percent_change_from_52_week_high="-85.96%"
percent_change_from_52_week_low="+19.05%"
previous_close="1.20"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.87"
price_per_sales="5.28"
revenue="12.04M"
shares_outstanding="52923000"
short_ratio="4.53"
stock_exchange="NGM"
symbol="RGLS"
volume="1320653"
weeks_range_52="1.05 - 8.90"
